From the beginning of July, it will be possible in Austria, for example, to go dancing in a nightclub, provided that the person in question proves that he has been vaccinated, tested negative or infected with the Covid-19 virus. So far, capacity restrictions will apply to these businesses, but on July 22, they will decrease as well.
From July 1, it will be possible to sit in an Austrian restaurant without a headscarf. On public transport, in enclosed public places, in shops or museums, it will be possible to wear only the normal headscarf in place of the FFP2 respirator masks.
Austrian Tourism Minister Elisabeth Kostingerova, in the field of gastronomy, said that the obligation to register will be rescinded on July 22. Conditions for organizing major cultural and sporting events will also be relaxed. From July 1, they will be able to conduct events without restrictions on the number of visitors or capacity restrictions.
According to Chancellor Sebastian Kurz, the situation around the coronavirus epidemic in the country is “much better” than expected. Kurz said the seven-day infection rate, the number of new infections per 100,000 residents in the last week, is now around 15 in Austria, and also praised progress in vaccination and testing. “The situation is very, very good,” he said.
Low efficacy of Curevac
The results of the preliminary analysis showed that the German company Curevac has an efficacy of only forty-seven percent against various dangerous forms of the disease, and therefore did not meet the established criteria.
40,000 people in ten countries in Latin America and Europe took part in vaccine tests. There were 13 different types of coronavirus. Final exams will continue and results are expected within a few weeks.
“We had hoped for better results in the ongoing analysis, but we expected high efficacy to be a major challenge with many coronavirus variants,” said Franz Werner Haas, Curevac Chairman. According to some media, the results are a blow to a vaccine based on the so-called RNA intermediate technology, which is already used by Pfizer / BioNTech and Moderna.
“Proud twitter enthusiast. Introvert. Hardcore alcohol junkie. Lifelong food specialist. Internet guru.”